Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.
暂无分享,去创建一个
M. King | D. Easton | M. Stratton | B. Ponder | J. Benítez | L. Cannon-Albright | R. Scott | K. Offit | Å. Borg | J. Boyd | P. Devilee | J. Garber | S. Neuhausen | A. Godwin | R. Gershoni-baruch | A. Osorio | T. Bishop | S. Narod | F. Lalloo | D. Goldgar | B. Weber | E. Teugels | E. Oláh | M. Caligo | E. Schubert | B. Csókay | O. Serova | D. Stoppa-Lyonnet | M. Schwab | A. Schofield | R. Scott | R. Scott | R. Scott
[1] B. Modan,et al. Could the 185 deIAG BRCA1 Mutation Be an Ancient Jewish Mutation? , 1997, European journal of human genetics : EJHG.
[2] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[3] M. King,et al. Population genetics of BRCA1 and BRCA2. , 1997, American journal of human genetics.
[4] Å. Borg,et al. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. , 1997, American journal of human genetics.
[5] I. Lerer,et al. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. , 1997, American journal of human genetics.
[6] S. Seal,et al. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene , 1997, Nature Genetics.
[7] D. B. Berman,et al. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families , 1996, Nature Medicine.
[8] Alfred A. Boyd,et al. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2 , 1996, Nature Genetics.
[9] Kenneth Offit,et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% , 1996, Nature Genetics.
[10] J. Rommens,et al. Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. , 1996, Genomics.
[11] K Offit,et al. Germline BRCA1 185delAG mutations in Jewish women with breast cancer , 1996, The Lancet.
[12] D. Stoppa-Lyonnet,et al. Breast cancer and BRCA1 mutations. , 1996, The New England journal of medicine.
[13] Kenneth Offit,et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer , 1996, Nature Genetics.
[14] Cécile Fizames,et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites , 1996, Nature.
[15] J. Rommens,et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds , 1996, Nature Genetics.
[16] Julian Peto,et al. Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.
[17] M. King,et al. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. , 1996, American journal of human genetics.
[18] F. Couch,et al. Mutations and Polymorphisms in the familial early‐onset breast cancer (BRCA1) gene , 1996, Human mutation.
[19] F. Collins,et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals , 1995, Nature Genetics.
[20] P. Tonin,et al. BRCA1 mutations in Ashkenazi Jewish women. , 1995, American journal of human genetics.
[21] D. Cox,et al. Haplotypes and mutations in Wilson disease. , 1995, American journal of human genetics.
[22] R. Glass,et al. Frontometaphyseal dysplasia: neonatal radiographic diagnosis. , 1995, American journal of medical genetics.
[23] M. Skolnick,et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. , 1995, JAMA.
[24] N. Risch,et al. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population , 1995, Nature Genetics.
[25] D. Easton,et al. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.
[26] B S Weir,et al. Likelihood methods for locating disease genes in nonequilibrium populations. , 1995, American journal of human genetics.
[27] J. Klijn,et al. Rapid detection of BRCA1 mutations by the protein truncation test , 1995, Nature Genetics.
[28] Francis S. Collins,et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer , 1994, Nature Genetics.
[29] J. Rommens,et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families , 1994, Nature Genetics.
[30] Patrick Dowd,et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families , 1994, Nature Genetics.
[31] L. Cannon-Albright,et al. A P1-based physical map of the region from D17S776 to D17S78 containing the breast cancer susceptibility gene BRCA1. , 1994, Human molecular genetics.
[32] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[33] J. Weber,et al. Mutation of human short tandem repeats. , 1993, Human molecular genetics.
[34] X. Estivill,et al. Haplotype analysis to determine the position of a mutation among closely linked DNA markers. , 1993, Human molecular genetics.
[35] X. Estivill,et al. Microsatellite haplotypes for cystic fibrosis: mutation frameworks and evolutionary tracers. , 1993, Human molecular genetics.
[36] Eric Lander,et al. Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland , 1992, Nature Genetics.
[37] G. Lenoir,et al. Familial breast-ovarian cancer locus on chromosome 17q12-q23 , 1991, The Lancet.
[38] T. Sekiya,et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.
[39] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.